Nasal administration of cholera toxin B subunit-nerve growth factor improves the space learning and memory abilities in β-amyloid protein25-35-induced amnesic mice

Neuroscience

Volumn 155, Issue 1, 2008, Pages 234-240

  Zhang, Q ^a   Liu, Y ^a   Yang, N ^a   Wan, X ^a   Zuo, P ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

A 25 35 induced amnesic mice; CB NGF; nasal administration; PC12 cells; spatial learning and memory

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; CHOLERA TOXIN B SUBUNIT; CHOLERA TOXIN B SUBUNIT PLUS NERVE GROWTH FACTOR; CHOLINE ACETYLTRANSFERASE; NERVE GROWTH FACTOR; PERIODATE SODIUM;

ALZHEIMER DISEASE; AMNESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DRUG DOSE COMPARISON; FOREBRAIN; IN VITRO STUDY; IN VIVO STUDY; LEARNING; MALE; MEMORY; METHODOLOGY; MOUSE; NERVE FIBER GROWTH; NEUROPROTECTION; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; AMNESIA; AMYLOID BETA-PROTEIN; ANIMALS; BEHAVIOR, ANIMAL; CHOLERA TOXIN; CHOLINE O-ACETYLTRANSFERASE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; LEARNING; MALE; MAZE LEARNING; MICE; MICE, INBRED BALB C; NERVE GROWTH FACTOR; NEURITES; PC12 CELLS; PEPTIDE FRAGMENTS; RATS; SPACE PERCEPTION; TIME FACTORS;

EID: 48949115058     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.05.040     Document Type: Article

References (30)

1. Al-Shawi R., Hafner A., Chun S., Raza S., Crutcher K., Thrasivoulou C., Simons P., and Cowen T. ProNGF, sortilin, and age-related neurodegeneration. Ann N Y Acad Sci 1119 (2007) 208-215
2. Benoit B.O., Savarese T., Joly M., Engstrom C.M., Pang L., Reilly J., Recht L.D., Ross A.H., and Quesenberry P.J. Neurotrophin channeling of neural progenitor cell differentiation. Neurobiology 46 (2001) 265-280
3. Chen X.Q., Fawcett J.R., Rahman Y.E., Ala T.A., and Frey II W.H. Delivery of nerve growth factor to the brain via the olfactory pathway. J Alzheimers Dis 1 (1998) 35-44
4. Cuello A.C., Bruno M.A., and Bell K.F. NGF-cholinergic dependency in brain aging, MCI and Alzheimer's disease. Curr Alzheimer Res 4 (2007) 351-358
5. Debeir T., Saragovi H.U., and Cuello A.C. A nerve growth factor mimetic TrKA antagonist causes withdrawal of cortical cholinergic boutons in the adult rat. Proc Natl Acad Sci U S A 96 (1999) 4067-4072
6. Durand M., Coronas V., Jourdan F., and Quirion R. Developmental and aging aspects of the cholinergic innervation of the olfactory bulb. Int J Dev Neurosci 16 (1998) 777-785
7. Fahnestock M., Michalski B., Xu B., and Coughlin M.D. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease. Mol Cell Neurosci 18 (2001) 210-220
8. Ito H., Nomoto H., Furukawa Y., and Furukawa S. Neurotrophins facilitate synthesis of choline acetyltransferase and tyrosine hydroxylase in cultured mouse neural stem cells independently of their neuronal differentiation. Neurosci Lett 339 (2003) 231-234
9. Jobling M.G., and Holmes R.K. Mutational analysis of ganglioside GM(1)-binding ability, pentamer formation, and epitopes of cholera toxin B (CTB) subunits and CTB/heat-labile enterotoxin Bsubunit chimeras. Infect Immun 70 (2002) 1260-1271
10. Jonhagen M.E. Nerve growth factor treatment in dementia. Alzheimer Dis Assoc Disord 14 (2000) S31-S38
11. Kar S., and Quirion R. Amyloid beta peptides and central cholinergic neurons: functional interrelationship and relevance to Alzheimer's disease pathology. Prog Brain Res 145 (2004) 261-274
12. Kar S., Slowikowski S.P., and Westaway D. Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease. J Psychiatry Neurosci 29 (2004) 427-441
13. Kozireski-Chuback D., Wu G., and Ledeen R.W. Upregulation of nuclear GM1 accompanies axon-like, but not dendrite-like, outgrowth in NG108-15 cells. J Neurosci Res 55 (1999) 107-118
14. Lad S.P., Neet K.E., and Mufson E.J. Nerve growth factor: structure, function and therapeutic implications for Alzheimer's disease. Curr Drug Targets CNS Neurol Disord 2 (2003) 315-334
15. Maccioni R.B., Munoz J.P., and Barbeito L. The molecular bases of Alzheimer's disease and other neurodegenerative disorders. Arch Med Res 32 (2001) 367-381
16. Miwa T., Moriizumi T., Horikawa I., Uramoto N., Ishimaru T., Nishimura T., and Furukawa M. Role of nerve growth factor in the olfactory system. Microsc Res Tech 58 (2002) 197-203
17. Mufson E.J., Ginsberg S.D., and Ikonomovic M.D. Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction. J Chem Neuroanat 26 (2003) 233-242
18. Mufson E.J., Counts S.E., Fahnestock M., and Ginsberg S.D. Cholinotrophic molecular substrates of mild cognitive impairment in the elderly. Curr Alzheimer Res 4 (2007) 340-350
19. Mutoh T., Hamano T., and Yano S. Stable transfection of GM1 synthase gene into GM1-deficient NG108-15 cells, CR-72 cells, rescues the responsiveness of Trk-neurotrophin receptor to its ligand, NGF. Neurochem Res 27 (2002) 801-806
20. Mutoh T., Tokuda A., Guroff G., and Fujiki N. The effect of the B subunit of cholera toxin on the action of nerve growth factor on PC12 cells. J Neurochem 60 (1993) 1540-1547
21. Nakane P.K., and Kawaoi A. Peroxidase-labeled antibody. A new method of conjugation. J Histochem Cytochem 22 (1974) 1084-1091
22. Perras B., Wagner U., Born J., and Fehm H.L. Improvement of sleep and pituitary-adrenal inhibition after subchronic intranasal vasopressin treatment in elderly humans. J Clin Psychopharmacol 23 (2003) 35-44
23. Pitrowsky R., Thiemann A., Kern W., Fehm H.L., and Born J. A nose-brain pathway for psychotropic peptides: evidence from a brain evoked potential study with cholecystokinin. Psychoneuroendocrinology 21 (1996) 559-572
24. Rabin S.J., Bachis A., and Mocchetti I. Gangliosides activate Trk receptors by inducing the release of neurotrophins. J Biol Chem 277 (2002) 49466-49472
25. Siegel G.J., and Chauhan N.B. Neurotrophic factors in Alzheimer's and Parkinson's disease brain. Brain Res Rev 33 (2000) 199-227
26. Song L., Che W., Min-Wei W., Murakami Y., and Matsumoto K. Impairment of the spatial learning and memory induced by learned helplessness and chronic mild stress. Pharmacol Biochem Behav 83 (2006) 186-193
27. Tannenbaum B.M., Tannenbaum G.S., and Anisman H. Impact of life-long macronutrient choice on neuroendocrine and cognitive functioning in aged mice: differential effects in stressor-reactive and stressor-resilient mouse strains. Brain Res 985 (2003) 187-197
28. Thorne R.G., Pronk G.J., Padmanabhan V., and Frey II W.H. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience 127 (2004) 481-496
29. van Ginkel F.W., Jackson R.J., Yuki Y., and McGhee J.R. Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues. J Immunol 165 (2000) 4778-4782
30. Wan X.C., Shang J.Z., and Cao C.C. Gangliosides in dendritic flow and the Golgiphobic dendrites as revealed by choleragenoid-horseradish peroxidase conjugate (CB-HRP). Neurosci Lett 20 Suppl (1985) S15